Subscribe
Jocelyn Ulrich of the Pharmaceutical Research and Manufacturers of America (PhRMA), testified at the Senate Committee Hearing
23 May 2024NewsBig PharmaSarah Speight

Senators grill witnesses in bid to pin patent abuse on Big Pharma

US Senate committee accuses drug companies of ‘gaming’ the patent system | Industry representatives interrogated during hearing | ‘Playing games with patents has to stop’, says one Senator.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
US agency warns 10 pharma companies of filing ‘bogus’ patents
2 May 2024   AstraZeneca, GSK and Teva among manufacturers accused of “improper” submission of patents | More than 300 patents targeted in second wave of challenges by Federal Trade Commission | ‘Junk patents’ block competition and ramp up prices unfairly, says FTC chair.
Big Pharma
Humira: lessons from 20 years of patents, pricing and profits
21 March 2023   As AbbVie’s multibillion-dollar blockbuster drops over the patent cliff, is it time to tighten up patent and pricing strategies in the US? Sarah Speight investigates.
Big Pharma
AbbVie accused of delay tactics in $1.3bn Humira dispute
16 November 2023   Big pharma company relies on procedural arguments to fend off a complaint alleging that it engaged in excessive pricing | Feud centres on one of the most successful blockbuster drugs of all time.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Big Pharma
US agency warns 10 pharma companies of filing ‘bogus’ patents
2 May 2024   AstraZeneca, GSK and Teva among manufacturers accused of “improper” submission of patents | More than 300 patents targeted in second wave of challenges by Federal Trade Commission | ‘Junk patents’ block competition and ramp up prices unfairly, says FTC chair.
Big Pharma
Humira: lessons from 20 years of patents, pricing and profits
21 March 2023   As AbbVie’s multibillion-dollar blockbuster drops over the patent cliff, is it time to tighten up patent and pricing strategies in the US? Sarah Speight investigates.
Big Pharma
AbbVie accused of delay tactics in $1.3bn Humira dispute
16 November 2023   Big pharma company relies on procedural arguments to fend off a complaint alleging that it engaged in excessive pricing | Feud centres on one of the most successful blockbuster drugs of all time.

More on this story

Big Pharma
US agency warns 10 pharma companies of filing ‘bogus’ patents
2 May 2024   AstraZeneca, GSK and Teva among manufacturers accused of “improper” submission of patents | More than 300 patents targeted in second wave of challenges by Federal Trade Commission | ‘Junk patents’ block competition and ramp up prices unfairly, says FTC chair.
Big Pharma
Humira: lessons from 20 years of patents, pricing and profits
21 March 2023   As AbbVie’s multibillion-dollar blockbuster drops over the patent cliff, is it time to tighten up patent and pricing strategies in the US? Sarah Speight investigates.
Big Pharma
AbbVie accused of delay tactics in $1.3bn Humira dispute
16 November 2023   Big pharma company relies on procedural arguments to fend off a complaint alleging that it engaged in excessive pricing | Feud centres on one of the most successful blockbuster drugs of all time.

More features

Bayer gains exclusive licence for heart drug in Japan
McGuireWoods expands team with ex-Novo Nordisk GC
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent
‘We took Ravgen head-on’: How we won zero-damages and others didn't
Bristol Myers Squibb leader named INTA 2025 president